OneVentures • 26 March 2015

Hatchtech Pty Ltd to explore strategic alternatives for commercialization of Xeglyze™ lotion in the U.S.

OneVentures

Learn More

You may also like

02 August 2020

Healthcare

FDA Approves Xeglyze™ for the topical treatment of head lice infestation


02 August 2020

Healthcare

Hatchtech gets lice treatment nod from FDA


01 February 2018

OneVentures

No nit picking: Head lice group Hatchtech gets green light to trials


14 September 2015

OneVentures

Hatchtech inks $279m head lice deal as VC market comes to life


View All